Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations.
Ori J Lieberman, Vanja C Douglas, Sara C LaHue
Author Information
- Ori J Lieberman: Department of Neurology, University of California, San Francisco, CA, USA. ori.lieberman@ucsf.edu.
- Vanja C Douglas: Department of Neurology, University of California, San Francisco, CA, USA.
- Sara C LaHue: Department of Neurology, University of California, San Francisco, CA, USA.
No abstract text available.
- JAMA. 2019 Oct 22;322(16):1589-1599
[PMID: 31638686]
- Int J Geriatr Psychiatry. 2017 Oct;32(10):1079-1084
[PMID: 27561376]
- Nat Rev Dis Primers. 2020 Nov 12;6(1):90
[PMID: 33184265]
- Int Psychogeriatr. 2010 Aug;22(5):812-8
[PMID: 20353624]
- Am J Geriatr Psychiatry. 2005 Dec;13(12):1100-6
[PMID: 16319303]
- JAMA Netw Open. 2023 Jan 3;6(1):e2249950
[PMID: 36607634]
- Lancet. 2010 Nov 27;376(9755):1829-37
[PMID: 21056464]
- J Am Geriatr Soc. 2018 Sep;66(9):1805-1811
[PMID: 29851022]
- Crit Care. 2022 Dec 6;26(1):377
[PMID: 36474266]
- J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S282-8
[PMID: 22091574]
- Alzheimers Dement. 2018 Jul;14(7):944-951
[PMID: 29706487]
- J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):764-72
[PMID: 18693233]
- Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1376-86
[PMID: 26984612]
- Crit Care Med. 2009 May;37(5):1762-8
[PMID: 19325490]
- Alzheimers Dement. 2022 Oct 11;:
[PMID: 36218161]
Humans
Cholinesterase Inhibitors
Critical Illness
Delirium
Brain Diseases
Cholinesterases
Brain
Cholinesterase Inhibitors
Cholinesterases
